monitoring of the non-specific metabolites of organophosphate pesticide in amniotic fluid of...

1
S156 Abstracts / Toxicology Letters 189S (2009) S57–S273 which progressed to maximal severity of seizures and fascicula- tions within 60 min. At this time interval, biomarkers of cerebral ROS generation (F2-isoprostanes, F2-IsoPs; F4-neuroprostanes, F4- NeuroPs) were elevated to 142% and 225% of control, respectively. In addition, elevation of citrulline (a marker of RNS) by a 4- to 6-fold resulted in significant (p < 0.001) depletion of high-energy phosphates (ATP and phosphocreatine). Quantitative morphome- tric analysis of pyramidal neurons of the hippocampal CA1 region 1 h post DFP exposure revealed significant decreases in dendritic lengths and spine density to 30% and 58% of control, respec- tively. Pretreatment of rats, 30min prior to DFP exposure, with memantine (18 mg/kg, s.c.) in combination with atropine sul- fate (16mg/kg, s.c.), markedly attenuated DFP-induced increases in F2-IsoPs, F4-NeuroPs, citrulline and declines in high-energy phosphates and their metabolites. Furthermore, memantine pre- treatment also protected neurons in the CA1 hippocampal area from DFP-induced dendritic degeneration. These results suggest that memantine provides neuroprotection by suppressing cerebral oxidative/nitrosative stress involving multiple mechanisms (sup- ported by NINDS NS057223). doi:10.1016/j.toxlet.2009.06.761 Y19 Cotinine biomarker validation of self reported smoking status among Greek adolescents: The HELENA study Constantine Vardavas 1,, Manolis Tzatzarakis 1 , Maria Plada 1 , Aristeidis Tsatsakis 2 , Alina Papadaki 2 , Wim Saris 3 , Luis Moreno 4 , Anthony Kafatos 2 1 University of Crete, Department of Social Medicine, Faculty of Medicine, Heraklion, Crete, Greece, 2 University of Crete, Department of Forensic Sciences & Toxicology, Medical School, Heraklion, Greece, 3 University of Maastricht, Nutrition and Toxicology Research in Maastricht (NUTRIM), Department of Human Biology, Maastricht, Netherlands, 4 Universidad de Zaragoza, Escuela Universitaria de Ciencias de la Salud, Saragoza, Spain Question: A major problem in evaluating active smoking status, especially among adolescents, is its accurate verification, as adoles- cents usually underreport their current smoking status. We aimed at validating their self reported smoking status among adolescents of the HELENA, Heraklion cohort using serum cotinine. Methods: As part of the European HELENA study, 400 adoles- cents from Crete, Greece were randomly selected and contacted out of which 341 agreed to participate, of which 311 were within the valid age range (77.8% response rate) and questionnaire data was collected through personal interviews. Blood samples were collected from a random sample of 111 adolescents (of the 142 randomly selected, 78.2%) of which 106 were analysed for their cotinine concentrations with GC/MS. Results: In addition to the adolescents who were self reported current smokers (at least one cigarette during the last month), the cotinine analysis revealed another four participants with cotinine levels above that of the cut-off (cotinine>15ng/ml), with serum cotinine levels of 28.86, 38.54, 132.61, and 290.97ng/ml, respec- tively, despite them having reported that they were non-smokers. Moreover, the analysis indicated that 4% of the non-smoking adolescents were actually smokers, despite their self reported non- smoking status. Conclusions: The applied questionnaire procedure successfully identified 96% of the active smokers, with only a small percentage of smokers found to report otherwise. This information provides support of the procedures validity in assessing the lifestyle habits of the adolescents participating in the HELENA study. doi:10.1016/j.toxlet.2009.06.762 Y20 Monitoring of the non-specific metabolites of organophosphate pesticide in amniotic fluid of pregnant women in the region of Crete Manolis Tzatzarakis 1,, Dimitrios Koutroulakis 2 , Stavros Sifakis 2 , Matthaios Kavalakis 1 , Maria Tutudaki 1 , Nikitas Mantas 2 , Ourania Koukoura 2 , Manolis Kokkinakis 1 , Ioannis Mataliotakis 2 , Aristidis Tsatsakis 2 1 University of Crete, Laboratory of Toxicology, Medical School, Heraklion, Greece, 2 University Hospital, Obstetrics and Gynecology, Fetal Maternal Unit, Heraklion, Greece Purpose: The levels of the non-specific metabolites of organophos- phate pesticides (DAPs) in amniotic fluid were determined in the present study, in order to assess exposure of pregnant women to organophosphate pesticides. The examined metabolites were dimethylphosphate (DMP), diethylphosphate (DEP), diethylthio- phosphate (DETP), and diethyldithiophosphate (DEDTP). These metabolites are polar water soluble substances, can be detected in several biological samples like urine, blood, meconium, hair and are considered as biomarkers of exposure to a great number of organophosphate pesticides. Method: During 2007–2008, 200 amniotic samples were col- lected from pregnant women, permanent residents of Crete. The collection of amniotic samples was performed at 17–24 week of pregnancy, during amniocentesis for fetal karyotype investi- gation. An amount of 5 ml of amniotic fluid was collected and stored at 20 C until analysis. DAPs were extracted from amni- otic fluid by liquid–liquid extraction, derivitized and analyzed by gas chromatography–mass spectrometry (GC–MS). Results: The mean values (±SD) and the range of DMP, DEP, DETP and DEDTP in positive amniotic samples were 14.63 ± 38.27 ng/ml (0.22–252.01), 8.65 ± 29.54 ng/ml (0.17–356.85), 12.60 ± 119.95 ng/ml (0.12–1449.87), and 0.34 ± 0.67 ng/ml (0.05–5.13), respectively. DEP was the metabolite with the higher frequency of detection (90.5%) followed by DETP (74.0%), DMP (60.0%), and DEDTP (39.5%). Conclusion: The high frequency of detection of all DAPs is prob- ably an indication of the widespread use of organophosphate pesticides in the region of Crete. The correlation of the detected levels of pesticide metabolites in amniotic fluid with a variety of parameters of pregnancy outcome including congenital abnor- malities, pregnancy-associated complications (intrauterine growth restriction, preterm labor, and stillbirth), birth weight, and neona- tal morbidity may be valuable in prenatal screening and pregnancy surveillance. Further studies and more data are required before the aforementioned goal is achieved. doi:10.1016/j.toxlet.2009.06.763

Upload: manolis-tzatzarakis

Post on 30-Nov-2016

212 views

Category:

Documents


0 download

TRANSCRIPT

S156 Abstracts / Toxicology Letters 189S (2009) S57–S273

which progressed to maximal severity of seizures and fascicula-tions within 60 min. At this time interval, biomarkers of cerebralROS generation (F2-isoprostanes, F2-IsoPs; F4-neuroprostanes, F4-NeuroPs) were elevated to 142% and 225% of control, respectively.In addition, elevation of citrulline (a marker of RNS) by a 4- to6-fold resulted in significant (p < 0.001) depletion of high-energyphosphates (ATP and phosphocreatine). Quantitative morphome-tric analysis of pyramidal neurons of the hippocampal CA1 region1 h post DFP exposure revealed significant decreases in dendriticlengths and spine density to 30% and 58% of control, respec-tively. Pretreatment of rats, 30 min prior to DFP exposure, withmemantine (18 mg/kg, s.c.) in combination with atropine sul-fate (16 mg/kg, s.c.), markedly attenuated DFP-induced increasesin F2-IsoPs, F4-NeuroPs, citrulline and declines in high-energyphosphates and their metabolites. Furthermore, memantine pre-treatment also protected neurons in the CA1 hippocampal areafrom DFP-induced dendritic degeneration. These results suggestthat memantine provides neuroprotection by suppressing cerebraloxidative/nitrosative stress involving multiple mechanisms (sup-ported by NINDS NS057223).

doi:10.1016/j.toxlet.2009.06.761

Y19Cotinine biomarker validation of self reported smoking statusamong Greek adolescents: The HELENA study

Constantine Vardavas 1,∗, Manolis Tzatzarakis 1, Maria Plada 1,Aristeidis Tsatsakis 2, Alina Papadaki 2, Wim Saris 3, LuisMoreno 4, Anthony Kafatos 2

1 University of Crete, Department of Social Medicine, Faculty ofMedicine, Heraklion, Crete, Greece, 2 University of Crete, Departmentof Forensic Sciences & Toxicology, Medical School, Heraklion, Greece,3 University of Maastricht, Nutrition and Toxicology Research inMaastricht (NUTRIM), Department of Human Biology, Maastricht,Netherlands, 4 Universidad de Zaragoza, Escuela Universitaria deCiencias de la Salud, Saragoza, Spain

Question: A major problem in evaluating active smoking status,especially among adolescents, is its accurate verification, as adoles-cents usually underreport their current smoking status. We aimedat validating their self reported smoking status among adolescentsof the HELENA, Heraklion cohort using serum cotinine.

Methods: As part of the European HELENA study, 400 adoles-cents from Crete, Greece were randomly selected and contactedout of which 341 agreed to participate, of which 311 were withinthe valid age range (77.8% response rate) and questionnaire datawas collected through personal interviews. Blood samples werecollected from a random sample of 111 adolescents (of the 142randomly selected, 78.2%) of which 106 were analysed for theircotinine concentrations with GC/MS.

Results: In addition to the adolescents who were self reportedcurrent smokers (at least one cigarette during the last month), thecotinine analysis revealed another four participants with cotininelevels above that of the cut-off (cotinine>15 ng/ml), with serumcotinine levels of 28.86, 38.54, 132.61, and 290.97 ng/ml, respec-tively, despite them having reported that they were non-smokers.Moreover, the analysis indicated that 4% of the non-smokingadolescents were actually smokers, despite their self reported non-smoking status.

Conclusions: The applied questionnaire procedure successfullyidentified 96% of the active smokers, with only a small percentageof smokers found to report otherwise. This information provides

support of the procedures validity in assessing the lifestyle habitsof the adolescents participating in the HELENA study.

doi:10.1016/j.toxlet.2009.06.762

Y20Monitoring of the non-specific metabolites of organophosphatepesticide in amniotic fluid of pregnant women in the region ofCrete

Manolis Tzatzarakis 1,∗, Dimitrios Koutroulakis 2, Stavros Sifakis 2,Matthaios Kavalakis 1, Maria Tutudaki 1, Nikitas Mantas 2,Ourania Koukoura 2, Manolis Kokkinakis 1, Ioannis Mataliotakis 2,Aristidis Tsatsakis 2

1 University of Crete, Laboratory of Toxicology, Medical School,Heraklion, Greece, 2 University Hospital, Obstetrics and Gynecology,Fetal Maternal Unit, Heraklion, Greece

Purpose: The levels of the non-specific metabolites of organophos-phate pesticides (DAPs) in amniotic fluid were determined in thepresent study, in order to assess exposure of pregnant womento organophosphate pesticides. The examined metabolites weredimethylphosphate (DMP), diethylphosphate (DEP), diethylthio-phosphate (DETP), and diethyldithiophosphate (DEDTP). Thesemetabolites are polar water soluble substances, can be detected inseveral biological samples like urine, blood, meconium, hair andare considered as biomarkers of exposure to a great number oforganophosphate pesticides.

Method: During 2007–2008, 200 amniotic samples were col-lected from pregnant women, permanent residents of Crete. Thecollection of amniotic samples was performed at 17–24 weekof pregnancy, during amniocentesis for fetal karyotype investi-gation. An amount of 5 ml of amniotic fluid was collected andstored at −20 ◦C until analysis. DAPs were extracted from amni-otic fluid by liquid–liquid extraction, derivitized and analyzed bygas chromatography–mass spectrometry (GC–MS).

Results: The mean values (±SD) and the range of DMP, DEP,DETP and DEDTP in positive amniotic samples were 14.63 ±38.27 ng/ml (0.22–252.01), 8.65 ± 29.54 ng/ml (0.17–356.85),12.60 ± 119.95 ng/ml (0.12–1449.87), and 0.34 ± 0.67 ng/ml(0.05–5.13), respectively. DEP was the metabolite with thehigher frequency of detection (90.5%) followed by DETP (74.0%),DMP (60.0%), and DEDTP (39.5%).

Conclusion: The high frequency of detection of all DAPs is prob-ably an indication of the widespread use of organophosphatepesticides in the region of Crete. The correlation of the detectedlevels of pesticide metabolites in amniotic fluid with a varietyof parameters of pregnancy outcome including congenital abnor-malities, pregnancy-associated complications (intrauterine growthrestriction, preterm labor, and stillbirth), birth weight, and neona-tal morbidity may be valuable in prenatal screening and pregnancysurveillance. Further studies and more data are required before theaforementioned goal is achieved.

doi:10.1016/j.toxlet.2009.06.763